US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Extraordinary General Meeting September 7, 2006

Uppsala, Sweden, 24 August 2006. Biacore International AB (SSE: BCOR) announces today its decision to invite the shareholders of Biacore International AB to an Extraordinary General Meeting of shareholders on September 7, 2006. A notice of the AGM is attached.About Biacore Biacore is a global supplier of systems for protein interaction analysis, an area of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. The Company’s systems generate unique data on the interactions between proteins and other molecules, including small molecules

Decision about extra shareholders meeting and application for delisting

Uppsala August 21, 2006. GE Healthcare, which after the completion of the public offer to the shareholders in Biacore, owns more than 98% of the shares in Biacore, has requested the board of directors of Biacore to convene an extraordinary shareholder’s meeting in Biacore as soon as possible for the election of a new board of directors for the company.As a result hereof, the board of directors of Biacore has resolved to convene an extraordinary shareholders’ meeting. The date for such shareholders’ meeting will be provided in the notice for the shareholder’s meeting. Further, the board of

HALF-YEAR REPORT JANUARY – JUNE 2006

• Biacore continued to make very good progress in the second quarter of 2006. Overall sales increased by 21% to SEK 161.6 million (133.1). This strong performance was again driven by the Americas and Europe where sales increased by 48% and 33% respectively. Sales in Asia declined. In the first six months of 2006, total sales grew by 20% to SEK 299.5 million (249.1). Excluding the effect of exchange rates, sales increased by 17%. • Operating income for the second quarter increased by 41% to SEK 33.1 million (23.4). This much improved operating result was due to the strong sales performance

Conference call regarding Half-Year Report January-June 2006

Biacore International AB will release its Half-Year Report January-June 2006 on Thursday, July 20, 2006To give you an opportunity to discuss the Company’s results with management, we hereby invite you to take part in a conference call on Thursday, July 20, 2006 at 10 am EST – which is 3 pm UK time and 4 pm CET. In case you wish to participate in the call, please call the following number in the UK a few minutes before the conference is due to start. +44 (0)20 7162 0025 Password: Biacore A replay of the call will be available until July 25, 2005. To listen, please call the following number:

Statement of the Board of Directors of Biacore International AB in relation to the public cash offer for the shares of Biacore International AB

Uppsala, June 20, 2006Background This statement is issued by the Board of Directors of Biacore International AB (publ) ("Biacore") pursuant to Item II.14 of the Näringslivets Börskommitté, NBK (the Swedish Industry and Commerce Stock Exchange Committee) Rules concerning Public Offers for the Acquisition of Shares (2003). GE Healthcare ("GEHC") has on June 20, 2006 announced a public cash offer to the shareholders of Biacore to acquire all outstanding shares in Biacore (the "Offer"). Biacore's shareholders are being offered to tender their shares to GEHC for the consideration of SEK 330 in

Biacore launches its Own Operation in China

Own sales and marketing organization will enhance company’s ability to capture this high growth market opportunityUppsala, Sweden, 11th May, 2006. Biacore International AB (Biacore) (SSE: BCOR) announced today that it has formally launched its own operation in China, and is taking over full business responsibility for its products in the People’s Republic of China. The new organization is designed to take Biacore’s business to the next stage of its development in the rapidly growing market for life science instrumentation in China. The new Chinese operation will be headed by Peter Lee, the

Annual General Meeting of Shareholders in Biacore International AB

Uppsala, Sweden, May 4, 2006. Biacore International AB (SSE: BCOR) announces that today’s Annual General Meeting of shareholders was attended by 23 shareholders, representing 61 percent of the total number of shares and votes in the Company.The meeting decided, in accordance with the board of directors’ and the president’s proposal, that the non-restricted equity in the Parent Company at the meeting’s disposal, SEK 85,312,000, be used as follows: Dividend to shareholders, SEK 3 per share SEK 29,250,000 To be carried forward as retained earnings SEK 56,062,000 Total SEK 85,312,000 The record

INTERIM REPORT JANUARY – MARCH 2006

.· Biacore continued to make progress in the first quarter of 2006. Overall sales increased by 19% to SEK 137.9 million (116.0). The higher than anticipated first quarter sales growth was driven by very strong performances in Europe and the Americas where sales increased by 53% and 41% respectively. Sales in Asia-Pacific declined. Excluding the effect of exchange rates, sales grew by 13% in the first three months of 2006. · Operating income for the first quarter increased by 122% to SEK 30.9 million (13.9). This much improved operating performance was the result of the growth in sales, an

Conference call regarding Interim Report January-March 2006

Biacore International AB will release its Interim Report January-March 2006 on Thursday, May 4, 2006To give you an opportunity to discuss the Company’s results with management, we hereby invite you to take part in a conference call on Thursday, May 4, 2006 at 8.30 am EST – which is 1.30 pm UK time and 2.30 pm CET. In case you wish to participate in the call, please call the following number in the UK a few minutes before the conference is due to start. +44 (0) 20 7162 0125 Password: Biacore A replay of the call will be available until May 9, 2005. To listen, please call the following number:

Biacore First Quarter Sales Update

Uppsala, Sweden, 11 April 2006. Biacore International AB (SSE:BCOR) announces today that its first quarter sales performance was better than current market expectations. In the first quarter 2006, sales increased by approximately 19% compared to the corresponding period in 2005. Biacore had anticipated a slowdown in its growth in the early part of 2006 following the record sales it achieved in the final quarter of 2005.Biacore’s interim report for the first quarter will be published on May 4, 2006, as previously announced. – Ends – For further information please contact: Erik Walldén,

Annual General Meeting May 4, 2006

Uppsala, Sweden, 6 April 2006. Biacore International AB (SSE: BCOR) announces today its decision to invite the shareholders of Biacore International AB to an Annual General Meeting of shareholders on May 4, 2006. A notice of the AGM is attached.About Biacore Biacore is a global supplier of systems for protein interaction analysis, an area of increasing importance for scientists in the academic, pharmaceutical, biotechnology and diagnostic markets. The Company’s systems generate unique data on the interactions between proteins and other molecules, including small molecules such as drug

THE BIACORE BOARD PROPOSES A NEW LONG TERM INCENTIVE PROGRAM

Uppsala, Sweden, April 4, 2006. The Board of Directors of Biacore International AB proposes that its shareholders resolve on a new Long Term Incentive Program. The shareholders will be asked to resolve on the plan at the Annual General Meeting to be held on May 4, 2006.Biacore shareholders have previously approved long term incentive plans in the years 2000, 2001, 2002, 2003 and 2005. The Biacore Board of Directors is convinced that the continuation of annual long-term incentive programs is essential to motivate and reward employees for achievements that are aligned with the shareholders’

YEAR-END REPORT 2005

.· Biacore had its most successful quarter ever in the final three months of 2005. Sales increased by 23% to SEK 193.7 million (157.1). The American market continued its recovery with sales up 48% to SEK 75.9 million and European sales increased by 45% to SEK 73.9 million. After a very strong performance earlier in the year, sales in Asia-Pacific declined by 20% in the fourth quarter. Biacore’s full-year 2005 sales rose by 15% to SEK 569.0 million (494.5). Excluding the effect of exchange rates, sales also grew by 15% in 2005. · Operating income for the fourth quarter was SEK 59.9 million (

Conference call regarding Year–end report 2005

Biacore International AB will release its Year–end report 2005 on Thursday, February 23, 2006.To give you an opportunity to discuss the Company’s results with management, we hereby invite you to take part in a conference call on Thursday, February 23, 2006 at 3 pm CET – which is 2 pm GMT time and 9 am EST. In case you wish to participate in the call, please call the following number in the UK a few minutes before the conference is due to start. +44 (0) 20 7162 0125 Password: Biacore A replay of the call will be available until February 24. To listen, please call the following number: +44 (0)

Biacore®A100 Continues to Make Further Commercial Progress

First US Order Received from Pharmaceutical Major Uppsala, Sweden, 17 November 2005. Biacore International AB (SSE: BCOR) is pleased to report further commercial progress with Biacore A100, its most advanced array-based system for protein interaction analysis.Biacore has today received a further order for Biacore A100 from one of the world’s major pharmaceutical companies, based in the U.S. The company intends to utilize the system to enhance its small molecule screening capabilities. The purchase decision was made after an evaluation of the capabilities of Biacore A100 to monitor the

Extraordinary Meeting of Shareholders

Uppsala, Sweden, October 20, 2005. Biacore International AB (SSE: BCOR) announces that today’s extraordinary meeting of shareholders was attended by 18 shareholders, representing 52 percent of the total number of shares and votes in the company. The meeting resolved in accordance with the board of directors’ proposal on the issuance of a debenture with subscription rights for new shares and approval of employee options as part of a new long term incentive program. The decision mainly involves the following: To secure obligations under the employee options, Biacore will issue a debenture

INTERIM REPORT JANUARY- SEPTEMBER 2005

· Biacore continued its recovery in the key American market with sales increasing by 21%. However, this was offset by lower sales in Europe (-14%) and Asia-Pacific (-27%). Total sales in the third quarter of 2005 amounted to SEK 126.2 million (134.1), a decline by 6%. During he first nine months 2005, sales increased by 11% to SEK 375.3 million (337.4) compared with the same period in 2004. Excluding the effect of exchange rates, total sales increased by 13%. · Operating income for the third quarter was SEK 23.6 million (-18.7). This strong increase is mainly due to the absence of non-

Conference call regarding Interim Report January – September 2005

Biacore International AB will release its Interim Report January – September 2005 on Thursday, October 20, 2005.To give you an opportunity to discuss the Company’s results with management, we hereby invite you to take part in a conference call on Thursday, October 20, 2005 at 3 pm CEST – which is 2 pm UK time and 9 a.m. EST time. In case you wish to participate in the call, please call the following number a few minutes before the conference is due to start. +44 (0) 20 7162 0084 Password: Biacore A replay of the call will be available until October 27. To listen, please call the following

New Order for Biacore®A100 Received from Major Pharmaceutical Company

Commercial Roll-Out of State of the Art System Continues at Several Major Protein Science Conferences Uppsala, Sweden, September 12, 2005. Biacore International AB (SSE: BCOR) is pleased to report further commercial progress with Biacore®A100, its most advanced array system for protein interaction analysisBiacore has today received its second order for Biacore®A100 from one of the world’s major European based pharmaceutical companies which intends to utilize the system to enhance its bio-therapeutic screening capabilities. In addition, Biacore®A100 was highlighted at the Developments in

THE BIACORE BOARD PROPOSES A NEW LONG TERM INCENTIVE PROGRAM

Uppsala, Sweden, September 12, 2005. The Board of Directors of Biacore International AB proposes that its shareholders resolve on a new Long Term Incentive Program. The shareholders will be asked to resolve on the plan at an Extraordinary General Meeting to be held on October 20, 2005.Biacore shareholders have previously approved long term incentive plans in the years 2000, 2001, 2002 and 2003. The Biacore Board of Directors is convinced that the continuation of annual long-term incentive programs is essential to motivate and reward employees for achievements that are aligned with the

HALF-YEAR REPORT JANUARY - JUNE 2005

· Biacore’s strong sales recovery continued in the second quarter of 2005 with sales increasing by 23% to SEK 133.1 million (107.9). The strongest sales performance was again seen in Asia-Pacific where sales grew by 94% in the quarter. Encouragingly, sales in the important American market also contributed to growth with an increase of 16% in the second quarter. Total sales in the first half-year 2005 increased by 23% to SEK 249.1 million (203.3). Excluding the effect of exchange rates, total sales increased by 26%. · Operating income for the second quarter was SEK 23.4 million (1.8). This

Conference call regarding Half-Year Report January – June 2005

Biacore International AB will release its Half-Year Report January – June 2005 on Tuesday, July 19, 2005. To give you an opportunity to discuss the Company’s results with management, we hereby invite you to take part in a conference call on Tuesday, July 19, 2005 at 3 pm CEST – which is 2 pm UK time and 9 a.m. EST time. In case you wish to participate in the call, please call the following number a few minutes before the conference is due to start. +44 (0) 20 7162 0084 Password: Biacore A replay of the call will be available until July 26. To listen, please call the following number: +44 (0)

There are no items matching the current filter
There are no more items matching the current filter
Back to top